Innovation Pharmaceuticals Inc (IPIX)

[BonelessCat]

From the first announcement of the PYMX acquisition and its details, I was immediately on-board. Yet, the entire market seemed opposed to it and regarded it a mistake as the Prurisol trial was at the same time delayed. Many here even called it a betrayal of shareholders focusing in on the minor AEs for Brilacidin and ignoring all presentations of data showing the AEs were more than controllable at lower and less frequent dosages. This attitude continued throughout 2014 until the price late that year began to recover after positive results and the QIDP designation.

My opinion continues that Brilacidin is now all but without risk. I will be right again. I may sometimes miss the timing through over optimism, but in 5 years I have yet to be wrong about efficacy and safety for each of the product lines.

Back to humility: thanks for the reminder of what we have had for two-and-a-half years, and that Cox is not the pumper clown many cast him.